share_log

Novo Nordisk's Wegovy Gets UK Approval as Preventative Treatment for Heart Problems in Obese, Overweight Adults

Novo Nordisk's Wegovy Gets UK Approval as Preventative Treatment for Heart Problems in Obese, Overweight Adults

诺和诺德公司的Wegovy获得了英国的批准,作为预防肥胖和超重成年人心脏问题的治疗。
MT Newswires ·  07/23 10:53

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发